[1] Matute C, Alberdi E, Ibarretxe G, et al.Excitotoxicity in glial cells[J].Eur J Pharmacol, 2002;447:239-46
[2] Ye Z, Sontheimer H.Modulation of glial glutamate transport through cell interactions with the extracellular matrix[J].Int J Dev Neurosci, 2002;20:209
[3] Seal RP, Amara SG.Excitatory amino acid transperters:a family in flux[J].Annu Rev Pharmacol Toxicol, 1999;39:431-56
[4] Niels C.Danbolt.Glutamate uptake[J].Prog Neurobiol, 2001;65:1-105
[5] Schluter K, Figiel M, Rozyczka J, et al.CNS region-specific regulation of glial glutamate transporter expression[J].Eur J Neurosci, 2002;16:836-42
[6] O'Shea R.Roles and regulation of glutamate transporters in the central nervous sy stem[J].Clin Exp Pharmacol Physiol, 2002; 29:1018-23
[7] Auger C, Attwell D.Fast removal of synaptic glutamate by postsynaptic transporters[J].Neuron, 2000;28:547-58
[8] Bridges RJ, Kavanaugh MP, Chamberlin AR.A pharmacological review of competitive inhibitors and subatrates of high-affinity, sodium-dependent glutamate transport in the central nervous system[J].Curr.Pharm Des, 1999;5:363-79
[9] Christopher M.Anderson, Raymond A et al.Astrocyte glutamate transport:Review of properties, regulation, and physiological functions[J].Glia, 2000;32:1-14
[10] Had-Aissouni L, Re DB, Nieoullon A.Importance of astrocytic inactivation of synaptically released glutamate for cell survival in the central nervous system-are astrocytes vulnerable to low intracellular glutamate concentrations[J] ? J Physiol Paris, 2002; 96:317-22
[11] Garthwaite G, Williams GD, Garthwaite J.Glutamate toxicityan experimental and theoretical analysis[J].Eur J Neurosci, 1992;4:353-60
[12] Nicholas J, Maragakis, Jeffrey D, et al.Glutamate transporters in neurologic disease[J].Basic Sci Semin Neurol, 2001;58: 365-70
[13] Shaw PJ.Calcium, glutamate, and amyotrophic lateral sclerosis: more evidence but on certainties[J].Ann.Neurol, 1999; 46:803-5
[14] Trotti D, Aoki M, Pasinelli P.Amyotrophic lateral sclerosislinked glutamate transporter mutant has impaired glutamate clearance capacity[J].J Biol Chem, 2001;276:576-82
[15] Alexander GM, Deitch JS, Seeburger JL.Elevated cortical extracellular fluid glutamate in transgenic mice expressing human mutant (G93A) Cu Zn superoxide dismutase[J].J Neurochem, 2000;74:1666-73
[16] Rothstein JD, Van KammenM, Levey, et al.Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis[J].Ann.Neurol, 1995;38:73-84
[17] Warita H, Manabe Y, Murakami T, et al.Tardive decrease of astrocytic glutamate transporter protein in transgenic mice with ALS-linked mutant SOD1[J].Neurol Res, 2002;24:577-81
[18] Heath PR, Shaw PJ.Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis[J].Muscle Nerve, 2002;26:438-58
[19] Cid C, Alvarez-Cermeno JC, Regidor I.Low concentrations of glutamate induce apoptosis in cultured neurons:Implications for amyotrophic lateral sclerosis[J].J Neurol Sci, 2003;206:91-5
[20] Deitch JS, Alexander GM, Del Valle L, et al.GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1[J].J Neurol Sci, 2002;193:117-26
[21] Harkany T, Hortobagyi T, Sasvari M, et al.Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity:relevance to Alzheimer's disease[J].Prog Neuropsy cho Pharmacol Biol Psy chiatry, 1999;23:963-1008
[22] Ferrarese C, Begni B, Canevari C, et al.Glutamate uptake is decreased in platelets from Alzheimer's disease patients[J]. Ann Neurol, 2000;47:641-3
[23] MattsonMP, Pedersen WA, Duan W, et al.Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases[J].Ann N Y Acad Sci, 1999;893:154-75
[24] Gadea A, Lopez-Colome AM.Glial transporters for glutamate, glycine and GABA I.Glutamate transporters[J].J Neurosci Res, 2001;63:453-60
[25] Plaitakis A, Shashidharan P.Glutamate transport and metabolism in dopaminergic neurons of substantia nigra:implications for the pathogenesis of Parkonson's disease[J].J.Neurol, 2000;247:Ⅱ 25-35
[26] Ferrarese C, Tremolizzo L, RigoldiM, et al.Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease[J].Neurol Sci, 2001;22:65-6
[27] Mattson MP, PedersenWA, Duan W, et al.Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases[J].Ann N Y Acad Sci, 1999;893:154-75
[28] Zipp F, Demisch L, Derouiche A, et al.Glutamine synthetase activity in patients with Parkinson's disease[J].Acta Neurol Scand, 1998;97:300-2
[29] Berman SB, Hastings TG.Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species[J].J Neurochem, 1997;69:1185-95
[30] Hazell AS, Itzhak Y, Liu H, et al.1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) decreases glutamate uptake in cultured astrocytes[J].J Neurochem, 1997;68:2216-9 |
